Lucid Diagnostics
About:
Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.
Website: http://www.luciddx.com
Twitter/X: LucidDiag
Description:
Lucid Diagnostics is a commercial-stage, cancer-prevention medical diagnostics company. Lucid focuses on patients with gastroesophageal disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid’s EsoGuard Esophageal DNA Test is performed on samples collected in a brief noninvasive office procedure with its EsoCheck Esophageal Cell Collection Device, a diagnostic test capable of serving as a widespread screening tool to prevent cancer and cancer deaths through early detection of esophageal precancer in at-risk GERD patients.
$30.2M
$1M to $10M
New York, New York, United States
2018-05-30
info(AT)luciddx.com
Shaun O'Neil
51-100
2024-05-07
Public
© 2025 bioDAO.ai